W e recently found published an article by Chatrath et al, 1 entitled "Soft-tissue Filler-associated Blindness: A Systematic Review of Case Reports and Case Series," in the last issue of the Journal. We read this valuable article with a great interest. The article emphasized an important and critical complication associated to filler and fat injection, blindness-associated filler injection, and aimed to review the cases of fillers in causing blindness and the association between hyaluronic acid filler and fat injection with blindness. The usage of soft-tissue fillers is growing, and these compounds are associated with certain adverse effects from minor local adverse effects to catastrophic vascular occlusive adverse effects such as blindness. Hence, it is necessary to address these adverse effects and the authors chose systematic review as a gold standard for this purpose. Systematic reviews and meta-analyses are crucial to summarize pervious published evidence relating to efficacy and safety of health care interventions accurately and reliably. It is necessary to follow certain guidelines for conducting a systematic review. Currently, Preferred Reporting Items for Systematic Reviews and Meta-Analyses is a well-known statement in this regard. 2 In addition to utilizing some software (eg, EndNote) to remove duplicated results, it is recommended to screen each result including cases one by one to avoid such fundamental mistakes. 4, 5 
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